Upload
trinhliem
View
215
Download
0
Embed Size (px)
Citation preview
82
DAFTAR PUSTAKA
1. G.K. Gupta, Agrawal Deepika , R.K. Arya, Prevalence risk factors and socio
demographic co – relates of adolescent hypertension in district
Ghaziabad.Indian Journal of community Health [internet]. c2013 [cited 2016
Jan 20]: 25(3):296-301. Available from: http://www.iapsmupuk.org/journal.
2. WHO. Non Communicable Disease: Hypertension [internet]. c2011 [cited
2015 Nov 11]. Available from: http://www.searo.who.int/.
3. Balitbang Kemenkes RI. Riset Kesehatan Dasar; RISKESDAS. Jakarta:
Balitbang Kemenkes RI; 2013.
4. RSUD RAA Soewondo. Profil RSUD RAA. Soewondo Pati Tahun 2014.
Pati: RSUD RAA Soewondo; 2014.
5. RSUD RAA Soewondo. 2014. Profil RSUD RAA. Soewondo Pati Tahun
2012. Pati: RSUD RAA Soewondo; 2014.
6. RSUD RAA Soewondo. Profil RSUD RAA. Soewondo Pati Tahun 2013.
Pati: RSUD RAA Soewondo; 2014.
7. Babatsikou F, Zavitsanou A. Epidemiology of hypertension in the eldery.
Health Sciene Journal [internet]. c2004 [cited 2015 dec 11] 4(10): 24-30.
Available from : http://www.hsj.gr/medicine/
8. Kim K, Kim YM, Kim EK. Correlation Between the Activities of Daily
Living of Stroke Patients in a Community Setting and Their Quality of Life.
Journal of Physical Therapy Science [internet]. c2014; 26 (3): 417-9.
Available from: http://www.ncbi.nlm.nih.gov
9. Anggraini, dkk. Faktor-faktor yang Berhubungan dengan Kejadian Hipertensi
pada Pasien yang Berobat di Poliklinik Dewasa Puskesmas Bangkinang
Periode Januari sampai Juni 2008 [internet]. c2009 [cited 2015 Nov 25].
Available from: http://yayanakhyar.files.wordpress.com/2009/
10. Chataut J, Adhikari RK, Sinha NP. Prevalence and Risk Factor for
Hypertension in Adults Living in Central Development Region in
Nepal.Kathmandu University Medical Journal [internet]. c2011 [cited 2015
Nov 25] 9(1):13-8. Available from: www.ncbi.com
83
11. Kartikasari. Faktor Risiko Hipertensi Pada Masyarakat di Desa Kabongan
Kidul, Kabupaten Rembang [Skripsi] Semarang: Universitas Diponegoro;
2012.
12. Achmad Choirun Ni’am, Berapa Faktor Resiko yang Berhubungan dengan
Kejadian Hipertensi,[Skripsi] Semarang; Universitas Muhammadiyah
Smearang; 2010.
13. Eva Puspita, dkk. Faktor Risiko Kejadian Hipertensi Pada Pasien yang
Berobat di Poliklinik Rumah Sakit Umum Daerah Labuang Baji
Makasar.Jurnal Ilmiah Kesehatan Diagnosis [internet]. c2014 [cited 2015
Nov 25]: 5(1):59-64.Available from: http:// library.stikesnh.ac.id
14. Charbel El Bcheraoui, Ziad A. Memish, Marwa Tuffaha, et al., Hypertension
and Its Associated Risk Factors in the Kingdom of Saudi Arabia, 2013: A
National Survey. International Journal of Hypertension [internet]. c2014
[cited 2015 Nov 25]: 2014(3);1-8.Available from :
www.hindawi.com/journals/
15. Syer Ree Tee dkk The Prevalence Of Hypertension And Its Associated Risk
Factors In Two Rural Communities In Penang, Malaysi.International e-
Journal of Science,Medicine dan education [internet]. c2010 [cited 2015 Nov
22]: 9(3):1-27. Available from : http://web.imu.edu.my/ejournal
16. Q Wei, J Sun, dkk. Prevalence of hypertension and associated risk factors in
Dehui City of Jilin Province in China.Journal of Human Hypertension
[internet]. c2015 [cited 2015 Nov 22]: 32(29), 64–8. Available from :
http://www.nature.com/jhh/journal
17. Reddy S S, Prabhu G R. Prevalence and Risk Factors of Hypertension in
Adults in an Urban Slum, Tirupati, A.P. Indian J Community Med [internet].
c2005 [cited 2016 Jan 20]: 30(3):84-6. Available from :
http://www.ijcm.org.in
18. Sathya Prakash Manimunda, dkk. Association of hypertension with risk
factors & hypertension related behaviour among the aboriginal Nicobarese
tribe living in Car Nicobar Island, Indi. Indian J Med Res [internet]. c2011
[cited 2016 Jan 20] ;133(3): 287–93. Available from :
http://www.ncbi.nlm.nih.gov
19. Gupta G.K, dkk. Prevalence risk factors and socio demographic co – relates
of adolescent hypertension in district Ghaziabad.Indian Journal of community
Health [internet]. c2013 [cited 2016 Jan 20]: 25(3):296-301. Available from :
https://doaj.org/toc/2248-9509/25/3
20. Mukhtar Z. Perubahan Hemodinamik dan Terapi Hipertensi dari Aspek
Kardiovaskuler. 1996. Jakarta: Bamboedoea. p: 24-5.
84
21. Sheldon G. Sheps. Mayo Clinic Hipertension (Terjemahan). Jakarta: Intisari
Mediatama; 2005. p: 26, 158.
22. Siregar TGM. Hipertesi esensial. Dalam: Rilantono et al. (ed). Buku ajar
kardiologi. 2003. Jakarta: FKUI
23. Yogiantoro M. Hipertensi Esensial. Dalam: Sudoyo et al. (ed). Buku ajar ilmu
penyakit dalam. Jilid I edisi IV. Jakarta: FKUI; 2006. p: 610-14.
24. Sheps SG. Mayo Clinic Hipertension (Terjemahan). Jakarta: Intisari
Mediatama; 2005. p: 26, 158.
25. Dharmeizar. Hipertensi. Medicinus Scientific Journal of Pharmacheutical
Development and Medical Application [internet]. c2012 [cited 2016 Jan 14].
25(10):5-6. Available from : http://www.dexa-medica.com
26. Andrea. Korelasi Derajat Hipertensi dengan Stadium Penyakit Ginjal Kronik
Di RSUP DR Kariadi periode 2008 - 2012 [Skripsi] Semarang: Universitas
Diponegoro; 2013.
27. Sari AAP, Kristiana IGAAW, dan Ayu NLPM. Gambaran Faktor-faktor
Determinan pada Pasien Hipertensi di Desa Sudimara Kecamatan Tabanan,
Kabupaten Tabanan Mei 2010 [internet]. c2010 [cited 2015 Nov 27]. p: 8.
Available from: http:// dc252.4shared.com/doc/
28. Martin J. Hypertension Guidelines: Revisiting The JNC 7 Recommendations.
The Journal of Lancaster General Hospital [internet]. c2008 [cited 2015 Des
6]: 3 (3):91-7. Available from : http://www.jlgh.org/JLGH/media/Journal
29. Mansjoer A, dkk. Kapita Selekta Kedokteran Jilid I: Nefrologi dan
Hipertensi. Jakarta: Media Aesculapius FK UI; 2001. p: 519-20.
30. Klasifikasi Hipertensi [internet]. c2009 Sep 14 [cited 2015 Nov 27].
Available from: http://www.dokter-medis.blogspot.com/
31. Kaplan NM. Primary Hipertension: pathogenesis. Kaplan’s clinical
Hypertension. 10th
edition. Philadelphia: Lippincot Williams & Wilkins;
2010. p. 44-108.
32. Klabunde R. Cardiovascular Physiologi Concept. Philadelphia: Lippincot
Williams & Wilkins; 2005.
33. Lopez-Sendon J, Swedenberg K, Mcmurray J, et al. Expert consensus
document on b-adrenergic receptor blocker: The Task Force on Beta-Blocker
of the European Society of Cardioligy. Eur Heart J. 2004; 25:1341-62.
85
34. de Groot AA, Mathy MJ, van Zwieten PA, et al. Involvement of the B3
Adrenoreceptor in Nebivolol-Induced Vasorelaxtion in Rat Aorta. J
Cardiovasc Pharmacol. 2003; 42:232-60.
35. Dzau VJ, Braundwald E, Resolved and unresolved issue in the prevention and
treatment of coronary artery disease: a workshop consensus steatment. Am
Heart J. 1991; 121:1244-63
36. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modiable risk
factor assosiated with myocardial infraction in 52 countries (the
INTERHEART study): case-control study. Lancet. 2004; 364:937-52.
37. Victor RG, Pathophysiology of Target-Organ Disease: Dose Angiotensin II
Remain The Key. J Clin Hypertension. 2007; 9(11): S4
38. Dzau VJ, Antman EM, Black HR, et al. The cardiovascular Disease
Continuum Validated: Clinical Evidence of Improved Patient Outcome.
Circulation. 2006; 114:2850-70.
39. Bonetti PO, Lerman LO, Lerman A. Endotelial Dysfungtion: A marker of
Atherosklerotic Risk. Arterioscler Thtomb Vasc Biol. 2003; 23:168-75.
40. Willerson JT, Kereiakes DJ. Endotelial dysfungtion. Circulation 2003; 108:
2060-1.
41. Strawn WB, Ferrario CM. Mechanism linking Angiotensin II and
Atherogenesis, Curr Opin Lipidol. 2002; 13:505-52.
42. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S,
Plaza JJ, Egido J. Role of the Renin Angiotensin System in Vasculare
Disease: Expending the Field. Hyperthension. 2001; 38: 1382.
43. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, dkk.
Hope study Investigators. Albuminuria and risk of cardiovascular events,
death, and heart failure in diabetic and non diabetic individuals. JAMA. 2001;
286: 421-6.
44. Lindholm LH, Ibsen H, Dahlof B, dkk. Cardiovaskular morbidity and
mortality in patients with diabetes in the Losartan Intervention for Endpoint
reduction in hypertension study (LIFE): a randomized trial against atenolol.
Lancet. 2002; 359:1004-10.
45. Hanifa A. Prevalensi Hipertensi Sebagai Penyebab Penyakit Ginjal Kronik Di
Unit Hemodialisis RSUP H.Adam Malik Medan Tahun 2009 [internet].
c2010 [cited 2015 Nov 27]. p: 4-13. Available from:
http://repository.usu.ac.id/
86
46. Sugiarto A. Faktor-faktor Risiko Hipertensi Grade II pada Masyarakat (Studi
Kasus di Kabupaten Karanganyar) [internet]. c2007 [cited 2015 Nov 27]. p:
29-50, 90-126. Available from: http://eprints.undip.ac.id/
47. Faktor Risiko Hipertensi yang Tidak dapat Dikontrol [internet]. c2011 [cited
2015 Nov 22]. Available from: http://smallcrab.com/kesehatan/
48. Nurkhalida. Warta Kesehatan Masyarakat. Jakarta : Depkes RI; 2003. p: 19-
21.
49. Lam Murni BR Sagala. Perawatan Penderita Hipertensi di Rumah oleh
Keluarga Suku Batak dan Suku Jawa di Kelurahan Lau Cimba Kabanjahe
[internet]. c2011 [cited 2015 Dec 4]. p: 10-13. Available from:
http://repository.usu.ac.id/
50. Sandhya Pruthi. Menopause and High Blood Pressure [internet]. c2010 [cited
2011 Nov 26]. Available from: http://www.mayoclinic.com/health/
51. Soetjiningsih. Tumbung kembang remaja dan permasalahannya. Jakarta:
Sagung Seto; 2004. p. 77-86.
52. Festy. Hubungan perilaku orang tua dengan kejadian obesitas pada anak pra-
sekolah (3-5 tahun) di Taman Flora kota Surabaya. Jurnal Penelitian Akademi
Kesehatan Rajekwesi Bojonegoro [internet]. c2012 [cited 2015 Dec 12]; 6(3):
22-6. Available from : https://jurnalakesrajekwesi.files
53. Anggara FHD, Prayitno N. Faktor-Faktor Yang Berhubungan dengan
Tekanan Darah di Puskesmas Telaga Murni, Cikarang Barat Tahun 2012.
Jurnal Ilmiah Kesehatan [internet]. c2013 [cited 2015 Dec 13]: 5(1):20-5.
Available from : http://lp3m.thamrin.ac.id
54. Natalia D, Hasibuan P, Hendro. Hubungan Obesitas dengan Kejadian
Hipertensi di Kecamatan Sintang, Kalimantan Barat. eJKI [internet]. c2014;
2(3):156-8. Available from : http://www.kalbemed.com/
55. Setyanda O, Sulastri D, Lestari Y. Hubungan Merokok dengan Kejadian
Hipertensi pada Laki-Laki Usia 35-65 Tahun di Kota Padang. Jurnal
Kesehatan andalas [internet]. c2015 [cited 2016 Jan 18]: 4(2): 434-9.
Available from : http://jurnal.fk.unand.ac.id.
56. Departemen Kesehatan Republik Indonesia. Pedoman Teknis Penemuan dan
Tatalaksana Penyakit Hipertensi. Jakarta: Departemen Kesehatan Republik
Indonesia; 2008. p. 14–28.
87
57. Departemen Kesehatan Republik Indonesia. Pedoman Surveilans Penyakit
Jantung dan Pembuluh Darah. Jakarta: Departemen Kesehatan Republik
Indonesia; 2008. p. 6.
58. Sherwood L. Pembuluh Darah dan Tekanan Darah. Dalam: Fisologi Manusia
dari Sel ke Sistem. Edisi 2. Jakarta: EGC; 2011. p.335–6.
59. Mukamal KJ. The Effects of Smoking on Cardiovascular Desease. Boston:
Departement of Interna Harvard Medical School; 2006. p.199.
60. Aris Sugiarto. Faktor–Faktor Risiko Hipertensi Grade II pada Masyarakat
(Studi Kasus di Kabupaten Karang Anyar) [internet]. c2007 [cited 2015 Dec
15]. p: 22-24, 77 – 79. Available from : http://eperintis.undip.ac.id/
61. National Institutes of Health. The Seventh Report of the Joint National
Committee on Prevention, Detection Evaluation, and Treatment of High
Blood Pressure, Atlanta: U. S. Department of Health and Human Services;
2004. p.31-5.
62. Brown C. Penyakit Aterosklerotik. Dalam: Price A, Wilson LM. Konsep
Klinis Proses–Proses Penyakit. Volume 1. Edisi 6. Jakarta: EGC; 2006. p.
582–7.
63. Kevin JW, John D. Nondrug Interventions for Treatment of Hypertension.
New York: Division of Cardiology University of Rochester Medical Center;
2011. p.231-89.
64. Dharmeizar. Hipertensi. Medicinus Scientific Journal of Pharmacheutical
Development and Medical Application [internet]. c2012 [cited 2016 Jan 14].
25(10):3-8. Available from : http://www.dexa-medica.com
65. Sartika, RAD. Pengaruh Lemak Trans Terhadap Kesehatan Jantung,
MAKARA Jurnal Sains [internet]. c2009 [cited 2016 Jan 10]; 13(1): 23-8.
Available from : http://jurnalkesmas.ui.ac.id
66. Shapo L, Pomerleau J, McKee M. Epidemiology of Hypertension and
Associated Cardiovascular Risk Factors in a Country in Transition. Journal
Epidemiology Community Health [internet]. c2003 [cited 2016 Jan 10];
57:734–9. Available from : http://www.ncbi.nlm.nih.gov\
67. Widyaningrum A T. Hubungan Asupan Natrium, Kalium, Magnesium dan
Status gizi dengan Tekanan Darah pada Lansia di Kalurahan Makamhaji
Kecamatan Kartasura. [internet]. c2014 [cited 2016 Jan 19]. p: 1-6. Available
from : http://eprints.ums.ac.id
88
68. Wijayanti E. Asupan Natrium dari Makanan Jajanan dan Tekanan Darah
Siswa Sekolah Dasar Studi di SD Negeri 06 Petompon. [internet]. c2010
[cited 2016 Jan 13]. p: 1. Available from : http://eprints.undip.ac.id
69. Bustan, MN. Epidemiologi penyakit menular, Jakarta: Rineka Cipta; 2007.
70. Komaling, JK, Suba, B, Wongkar, D. Hubungan Mengonsumsi Alkohol
dengan Kejadian Hipertensi pada Laki-laki Di Desa Tompasobaru II
Kecamatan Tompasobaru Kabupaten Minahasa Selatan. e-KP [internet].
c2013 [cited Jan 11]: 1(1): 25-30.
71. Susalit E, Kapojos EJ, Lubis HR. Hipertensi Primer Dalam Buku Ajar Ilmu
Penyakit Dalam, Edisi III, Jilid II, Jakarta: Balai Penerbit FKUI. 2001. p.453-
72.
72. Ganiswara. Farmakologi dan Terapan. Edisi IV. Jakarta: Bagian Farmakologi
FKUI; 1995. p. 317.
73. Yogiantoro, M. Hipertensi Esensial. Jakarta: Departemen Ilmu Penyakit
Dalam FKUI; 2006. p: 599-601.
74. Susalit E, Kapojos EJ, Lubis HR. Hipertensi Primer. Dalam: Buku Ajar Ilmu
Penyakit Dalam, Edisi III, Jilid II, Jakarta: Balai Penerbit FKUI. p. 453-70.
75. Mannan, H, Wahiduddin, Rismayanti. Faktor Risiko Kejadian Hipertensi di
Wilayah Kerja Puskesmas Bangkala Kabupaten Jeneponto Tahun 2011
Makassar [internet]. c2013 [cited 2016 April 18]. Available from:
http://repository.unhas.ac.id
76. Liu J, Sekine M, Tatsuse T, et al. Family history of hypertension and the risk
of overweight in Japanese children: results from the Toyama Birth Cohort
Study J Epidemiol [internet]. c2014 [cited 2016 Apr 18] 24(4):304–11.
Available from : http://www.ncbi.nlm.nih.gov/pubmed/24857956
77. Kumar V, Abbas AK, Fausto and, Hypertensive Vascular Disease. Dalam :
Robn and Cotran Pathologic basis of disease. Edisi 7. Philadeltia: Elsevier
Saunders, 2005. p. 528 – 9.
78. Pang W dkk. Prevalence of Hypertension and Associated Factors Among
Older Rural Adults: Results from Liaoning Province, China. Med Princ Pract
[internet]. c2010 [cited 2016 Apr 22]: 19(1):22–27. Available from :
http://dx.doi.org/10.1159/000252830
89
79. Niskanen L, dkk. Inflammation, abdominal obesity, and smoking as
predictors of hypertension. Hypertension [internet]. c2004 [cited 2016 Apr
24]: 44(6):859–865. Available from :
http://dx.doi.org/10.1161/01.HYP.0000146691.51307.84
80. Bowman ST et al. Clinical research Hypertension. A Prospective Study of
Cigarette Smokey And Risk of Inciden Hypertension In Bringham and
women Hospital Massachucettes [internet]. c2007 [cited 2016 Apr 25] :
50(21):2085-92. Available from: www.ncbi.nlm.nih.gov/pubmed/18021879
81. Stritzke J, Markus MP, Duderstadt S. Obesity is The Main Risk factor for
Left Atrial Enlargement during Aging. The MONICA/KORA (Monitoring of
Trends and Determinations in Cardiovascular Disease/Cooperative Research
in the Region of Augsburg) Study. J Am Coll Cardiol [internet]. c2009 Nov
[cited 2016 Apr 29]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/
82. Rahyani F. Epidemiologi Penderita Hipertensi Esensial yang Dirawat di
Bagian Penyakit Dalam Perjan RS DR. M. Djamil Padang Periode 1 Januari
2002 -31 Desember 2003. Skripsi. Padang. 2005. Hal 32
83. Ball CO, Meneely GR. Observations on Dietary Sodium Chloride. J Am Diet
Assoc [internet]. c1957 [cited 2016 Apr 29 ]: 33(4):366–370. Available from
: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105387/
84. Denton D, Weisinger R, Mundy Ni, Wickings EJ dkk. The Effect of Increased
Salt Intake on Blood Pressure of Chimpanzees. Nat Med [internet] c1995
[cited 2016 May 4]: 1(10): 1009-16. Available from :
http://www.ncbi.nlm.nih.gov/pubmed/7489355
85. Fukui M, Tanaka M, Toda H, Senmaru T, Sakabe K, Ushigome E, Nakamura
N. Risk Factors for Development of Diabetes Mellitus, Hypertension and
Dyslipidemia. Diabetes Res Clin Pract [internet] c2011 [cited 2016 May 10].
Available from : http://dx.doi.org/10.1016/j.diabres.2011.07.006 .
86. Halperin R. O., Sesso H. D., Ma J, Buring J. E., Stampfer M. J., Gaziano J.
M. Dyslipidemia and The Risk of Incident Hypertension in Men.
Hypertension. AHA Journal [internet] c2006 [cited 2016 May 7]:47(1):45–
50. Available from : http://dx.doi.org/10.1161/01.HYP.0000196306.42418.0e
.
87. Howard DS, Nancy RC, Julie EB, JoAnn EM, Michael G. Alcohol
Consumption and the Risk of Hypertension in Women and Men.
Hypertension [internet] c2008 [cited 2016 May 7]:51(4):1080-7. Available
from : http://www.ncbi.nlm.nih.gov/pubmed/18259032
90
Lampiran 1. Analisis Univariat Beberapa Variabel Bebas Terhadap Kondisi Tekanan
Darah Subjek dengan Menggunakan Uji Chi Aquare Program SPSS
Frequency Table
Umur
42 56.0 56.0 56.0
33 44.0 44.0 100.0
75 100.0 100.0
>= 55
< 55
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
Jenis Kelamin
31 41.3 41.3 41.3
44 58.7 58.7 100.0
75 100.0 100.0
Laki-laki
Perempuan
Total
ValidFrequency Percent Valid Percent
Cumulative
Percent
Pendidikan
38 50.7 50.7 50.7
37 49.3 49.3 100.0
75 100.0 100.0
Dasar
Menengah/Tinggi
Total
ValidFrequency Percent Valid Percent
Cumulative
Percent
91
Pekerjaan
19 25.3 25.3 25.3
11 14.7 14.7 40.0
11 14.7 14.7 54.7
2 2.7 2.7 57.3
23 30.7 30.7 88.0
9 12.0 12.0 100.0
75 100.0 100.0
Tidak bekerja
Buruh
Swasta
Wiraswasta
PNS/POLRI/TNI
Pensiunan
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
Tekanan Darah
49 65.3 65.3 65.3
26 34.7 34.7 100.0
75 100.0 100.0
Hipertensi II
Hipertensi I
Total
ValidFrequency Percent Valid Percent
Cumulative
Percent
BMI
47 62.7 62.7 62.7
28 37.3 37.3 100.0
75 100.0 100.0
Obese
Non Obese
Total
ValidFrequency Percent Valid Percent
Cumulative
Percent
Riw. Keluarga Hipertensi
49 65.3 65.3 65.3
26 34.7 34.7 100.0
75 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
92
Konsumsi Garam
70 93.3 93.3 93.3
5 6.7 6.7 100.0
75 100.0 100.0
Sering
Jarang
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
Konsumsi Lemak
72 96.0 96.0 96.0
3 4.0 4.0 100.0
75 100.0 100.0
Sering
Jarang
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
Kebiasan Merokok
17 22.7 22.7 22.7
58 77.3 77.3 100.0
75 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
Konsumsi Alkohol
4 5.3 5.3 5.3
71 94.7 94.7 100.0
75 100.0 100.0
Ya
Tidak
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
93
Olah raga teratur
40 53.3 53.3 53.3
35 46.7 46.7 100.0
75 100.0 100.0
Tidak
Ya
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
94
Lampiran 2. Analisis Bivariat Beberapa Variabel Bebas Terhadap Kondisi Tekanan
Darah Subjek dengan Menggunakan Uji Chi Aquare Program SPSS
Umur * Tekanan Darah
Crosstab
27 15 42
27.4 14.6 42.0
55.1% 57.7% 56.0%
22 11 33
21.6 11.4 33.0
44.9% 42.3% 44.0%
49 26 75
49.0 26.0 75.0
100.0% 100.0% 100.0%
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
>= 55
< 55
Umur
Total
Hipertensi II Hipertensi I
Tekanan Darah
Total
Chi-Square Tests
.046b 1 .830
.000 1 1.000
.046 1 .830
1.000 .513
.046 1 .831
75
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 11.
44.
b.
95
Symmetric Measures
.025 .830
75
Contingency CoefficientNominal by Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a.
Using the asymptotic standard error assuming the null hypothesis.b.
Risk Estimate
.900 .344 2.351
.964 .693 1.342
1.071 .570 2.013
75
Odds Ratio for Umur
(>= 55 / < 55)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
Value Lower Upper
95% Confidence
Interval
Jenis Kelamin * Tekanan Darah
Crosstab
21 10 31
20.3 10.7 31.0
42.9% 38.5% 41.3%
28 16 44
28.7 15.3 44.0
57.1% 61.5% 58.7%
49 26 75
49.0 26.0 75.0
100.0% 100.0% 100.0%
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Laki-laki
Perempuan
Jenis Kelamin
Total
Hipertensi II Hipertensi I
Tekanan Darah
Total
96
Chi-Square Tests
.135b 1 .713
.015 1 .903
.136 1 .712
.808 .453
.134 1 .715
75
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 10.
75.
b.
Symmetric Measures
.042 .713
75
Contingency CoefficientNominal by Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a.
Using the asymptotic standard error assuming the null hypothesis.b.
Risk Estimate
1.200 .454 3.171
1.065 .765 1.481
.887 .467 1.687
75
Odds Ratio for Jenis
Kelamin (Laki-laki /
Perempuan)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
Value Lower Upper
95% Confidence
Interval
97
Pendidikan * Tekanan Darah
Crosstab
24 14 38
24.8 13.2 38.0
49.0% 53.8% 50.7%
25 12 37
24.2 12.8 37.0
51.0% 46.2% 49.3%
49 26 75
49.0 26.0 75.0
100.0% 100.0% 100.0%
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Dasar
Menengah/Tinggi
Pendidikan
Total
Hipertensi II Hipertensi I
Tekanan Darah
Total
Chi-Square Tests
.161b 1 .688
.025 1 .874
.161 1 .688
.809 .437
.159 1 .690
75
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 12.
83.
b.
Symmetric Measures
.046 .688
75
Contingency CoefficientNominal by Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a.
Using the asymptotic standard error assuming the null hypothesis.b.
98
Risk Estimate
.823 .317 2.134
.935 .672 1.300
1.136 .609 2.121
75
Odds Ratio for
Pendidikan (Dasar /
Menengah/Tinggi)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
Value Lower Upper
95% Confidence
Interval
Pekerjaan * Tekanan Darah
Crosstab
10 9 19
12.4 6.6 19.0
20.4% 34.6% 25.3%
6 5 11
7.2 3.8 11.0
12.2% 19.2% 14.7%
10 1 11
7.2 3.8 11.0
20.4% 3.8% 14.7%
1 1 2
1.3 .7 2.0
2.0% 3.8% 2.7%
16 7 23
15.0 8.0 23.0
32.7% 26.9% 30.7%
6 3 9
5.9 3.1 9.0
12.2% 11.5% 12.0%
49 26 75
49.0 26.0 75.0
100.0% 100.0% 100.0%
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Tidak bekerja
Buruh
Swasta
Wiraswasta
PNS/POLRI/TNI
Pensiunan
Pekerjaan
Total
Hipertensi II Hipertensi I
Tekanan Darah
Total
99
Chi-Square Tests
5.492a 5 .359
6.160 5 .291
1.106 1 .293
75
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Assoc iation
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
5 cells (41.7%) have expected count less than 5. The
minimum expected count is .69.
a.
Symmetric Measures
.261 .359
75
Contingency CoefficientNominal by Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a.
Using the asymptotic standard error assuming the null hypothesis.b.
BMI * Tekanan Darah
Crosstab
33 14 47
30.7 16.3 47.0
67.3% 53.8% 62.7%
16 12 28
18.3 9.7 28.0
32.7% 46.2% 37.3%
49 26 75
49.0 26.0 75.0
100.0% 100.0% 100.0%
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Obese
Non Obese
BMI
Total
Hipertensi II Hipertensi I
Tekanan Darah
Total
100
Chi-Square Tests
1.323b 1 .250
.809 1 .368
1.310 1 .252
.318 .184
1.306 1 .253
75
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 9.
71.
b.
Symmetric Measures
.132 .250
75
Contingency CoefficientNominal by Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a.
Using the asymptotic standard error assuming the null hypothesis.b.
Risk Estimate
1.768 .667 4.688
1.229 .848 1.780
.695 .377 1.283
75
Odds Ratio for BMI
(Obese / Non Obese)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
Value Lower Upper
95% Confidence
Interval
101
Riw. Keluarga Hipertensi * Tekanan Darah
Crosstab
33 16 49
32.0 17.0 49.0
67.3% 61.5% 65.3%
16 10 26
17.0 9.0 26.0
32.7% 38.5% 34.7%
49 26 75
49.0 26.0 75.0
100.0% 100.0% 100.0%
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Ya
Tidak
Riw. Keluarga
Hipertensi
Total
Hipertensi II Hipertensi I
Tekanan Darah
Total
Chi-Square Tests
.253b 1 .615
.062 1 .804
.251 1 .616
.621 .399
.250 1 .617
75
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 9.
01.
b.
Symmetric Measures
.058 .615
75
Contingency CoefficientNominal by Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a.
Using the asymptotic standard error assuming the null hypothesis.b.
102
Risk Estimate
1.289 .479 3.470
1.094 .763 1.570
.849 .452 1.596
75
Odds Ratio for Riw.
Keluarga Hipertensi
(Ya / Tidak)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
Value Lower Upper
95% Confidence
Interval
Konsumsi Garam * Tekanan Darah
Crosstab
45 25 70
45.7 24.3 70.0
91.8% 96.2% 93.3%
4 1 5
3.3 1.7 5.0
8.2% 3.8% 6.7%
49 26 75
49.0 26.0 75.0
100.0% 100.0% 100.0%
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Sering
Jarang
Konsumsi
Garam
Total
Hipertensi II Hipertensi I
Tekanan Darah
Total
103
Chi-Square Tests
.509b 1 .476
.052 1 .820
.554 1 .457
.653 .430
.502 1 .479
75
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
2 cells (50.0%) have expected count less than 5. The minimum expected count is 1.
73.
b.
Symmetric Measures
.082 .476
75
Contingency CoefficientNominal by Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a.
Using the asymptotic standard error assuming the null hypothesis.b.
Risk Estimate
.450 .048 4.249
.804 .501 1.288
1.786 .301 10.600
75
Odds Ratio for Konsumsi
Garam (Sering / Jarang)
For cohort Tekanan Darah
= Hipertensi II
For cohort Tekanan Darah
= Hipertensi I
N of Valid Cases
Value Lower Upper
95% Confidence
Interval
104
Konsumsi Lemak * Tekanan Darah
Crosstab
47 25 72
47.0 25.0 72.0
95.9% 96.2% 96.0%
2 1 3
2.0 1.0 3.0
4.1% 3.8% 4.0%
49 26 75
49.0 26.0 75.0
100.0% 100.0% 100.0%
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Sering
Jarang
Konsumsi
Lemak
Total
Hipertensi II Hipertensi I
Tekanan Darah
Total
Chi-Square Tests
.002b 1 .960
.000 1 1.000
.002 1 .960
1.000 .726
.002 1 .961
75
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
2 cells (50.0%) have expected count less than 5. The minimum expected count is 1.
04.
b.
Symmetric Measures
.006 .960
75
Contingency CoefficientNominal by Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a.
Using the asymptotic standard error assuming the null hypothesis.b.
105
Risk Estimate
.940 .081 10.882
.979 .432 2.218
1.042 .204 5.324
75
Odds Ratio for Konsumsi
Lemak (Sering / Jarang)
For cohort Tekanan Darah
= Hipertensi II
For cohort Tekanan Darah
= Hipertensi I
N of Valid Cases
Value Lower Upper
95% Confidence
Interval
Kebiasan Merokok * Tekanan Darah
Crosstab
9 8 17
11.1 5.9 17.0
18.4% 30.8% 22.7%
40 18 58
37.9 20.1 58.0
81.6% 69.2% 77.3%
49 26 75
49.0 26.0 75.0
100.0% 100.0% 100.0%
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Ya
Tidak
Kebiasan
Merokok
Total
Hipertensi II Hipertensi I
Tekanan Darah
Total
106
Chi-Square Tests
1.490b 1 .222
.867 1 .352
1.448 1 .229
.255 .175
1.471 1 .225
75
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 5.
89.
b.
Symmetric Measures
.140 .222
75
Contingency CoefficientNominal by Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a.
Using the asymptotic standard error assuming the null hypothesis.b.
Risk Estimate
.506 .168 1.525
.768 .475 1.241
1.516 .805 2.857
75
Odds Ratio for Kebiasan
Merokok (Ya / Tidak)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
Value Lower Upper
95% Confidence
Interval
107
Konsumsi Alkohol * Tekanan Darah
Crosstab
2 2 4
2.6 1.4 4.0
4.1% 7.7% 5.3%
47 24 71
46.4 24.6 71.0
95.9% 92.3% 94.7%
49 26 75
49.0 26.0 75.0
100.0% 100.0% 100.0%
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Ya
Tidak
Konsumsi
Alkohol
Total
Hipertensi II Hipertensi I
Tekanan Darah
Total
Chi-Square Tests
.439b 1 .508
.015 1 .903
.419 1 .518
.606 .432
.433 1 .511
75
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
2 cells (50.0%) have expected count less than 5. The minimum expected count is 1.
39.
b.
Symmetric Measures
.076 .508
75
Contingency CoefficientNominal by Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a.
Using the asymptotic standard error assuming the null hypothesis.b.
108
Risk Estimate
.511 .068 3.852
.755 .280 2.041
1.479 .527 4.154
75
Odds Ratio for Konsumsi
Alkohol (Ya / Tidak)
For cohort Tekanan Darah
= Hipertensi II
For cohort Tekanan Darah
= Hipertensi I
N of Valid Cases
Value Lower Upper
95% Confidence
Interval
Olah raga teratur * Tekanan Darah
Crosstab
27 13 40
26.1 13.9 40.0
55.1% 50.0% 53.3%
22 13 35
22.9 12.1 35.0
44.9% 50.0% 46.7%
49 26 75
49.0 26.0 75.0
100.0% 100.0% 100.0%
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Tidak
Ya
Olah raga
teratur
Total
Hipertensi II Hipertensi I
Tekanan Darah
Total
109
Chi-Square Tests
.178b 1 .673
.032 1 .858
.178 1 .674
.809 .429
.175 1 .675
75
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea.
0 cells (.0%) have expected count less than 5. The minimum expected count is 12.
13.
b.
Symmetric Measures
.049 .673
75
Contingency CoefficientNominal by Nominal
N of Valid Cases
Value Approx. Sig.
Not assuming the null hypothesis.a.
Using the asymptotic standard error assuming the null hypothesis.b.
Risk Estimate
1.227 .473 3.182
1.074 .769 1.499
.875 .470 1.628
75
Odds Ratio for Olah
raga teratur (Tidak / Ya)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
Value Lower Upper
95% Confidence
Interval
110
Lampiran 3. Analisis Multivariat Beberapa Variabel yang Berhubungan dengan Kondisi
Tekanan Darah Subjek dengan Menggunakan Regresi Logistik Berganda Metode
Backward Stepwise (Likelihood Ratio) pada Program SPSS
Logistic Regression
Block 1: Method = Backward Stepwise (Likelihood Ratio)
Variables in the Equation
.723 .533 1.843 1 .175 2.061 .725 5.854
-.261 .615 .180 1 .672 .770 .231 2.573
1.222 .605 4.073 1 .044 3.394 1.036 11.118
-2.728 1.835 2.211 1 .137 .065
.755 .527 2.051 1 .152 2.127 .757 5.975
1.298 .579 5.022 1 .025 3.661 1.177 11.392
-3.328 1.185 7.890 1 .005 .036
1.164 .558 4.345 1 .037 3.203 1.072 9.571
-2.105 .757 7.740 1 .005 .122
BMI
Merokok
Obat
Constant
Step
1a
BMI
Obat
Constant
Step
2a
Obat
Constant
Step
3a
B S.E. Wald df Sig. Exp(B) Lower Upper
95.0% C.I.for EXP(B)
Variable(s) entered on step 1: BMI, Merokok, Obat.a.
Tabel Karakteristik Data
Variabel n %
Umur
≥ 55 42 56
< 55 33 44
Jenis kelamin
Laki-laki 31 41,3
Perempuan 44 58,7
Pendidikan
Dasar 38 50,7
Menengah/tinggi 37 49,3
Pekerjaan
111
Tidak bekerja 19 25,3
Buruh 11 14,7
Swasta 11 14,7
Wiraswasta 2 2,7
PNS/POLRI/TNI 23 30,7
Pensiunan 9 12
Tekanan darah
Hipertensi II 49 65,3
Hipertensi I 26 34,7
BMI
Obese 47 62,7
Non obese 28 37,3
Riw. Keluarga hipertensi
Ya 49 65,3
Tidak 26 34,7
Konsumsi garam
Sering 70 93,3
Jarang 5 6,7
Konsumsi lemak
Sering 72 96
Jarang 3 4
Kebiasaan merokok
Ya 17 22,7
Tidak 58 77,3
Konsumsi alkohol
Ya 4 5,3
Tidak 71 94,7
Olah raga teratur
112
Tidak 40 53,3
Ya 35 46,7
Tabel Hasil Uji Chi Square
Variabel
Hipertensi
p r IK 95% II I
n % n %
Umur
≥ 55 27 55,1 15 57,7 0,830§ 0,025 0,9 (0,34 – 2,35)
< 55 22 44,9 11 42,3
Jenis kelamin
Laki-laki 21 42,9 10 38,5 0,713§ 0,042 1,2 (0,45 – 3,17)
Perempuan 28 57,1 16 61,5
Pendidikan
Dasar 24 49 14 53,8 0,688§ 0,046 0,82 (0,32 – 2,13)
Menengah/tinggi 25 51 12 46,2
Pekerjaan
Tidak bekerja 10 20,4 9 34,6 0,359§ 0,261 –
Buruh 6 12,2 5 19,2
Swasta 10 20,4 1 3,8
Wiraswasta 1 2 1 3,8
PNS/POLRI/TNI 16 32,7 7 26,9
Pensiunan 6 12,2 3 11,5
BMI
Obese 33 67,3 14 53,8 0,250§ 0,132 1,77 (0,67 – 4,69)
Non obese 16 32,7 12 46,2
Riw. Keluarga
113
hipertensi
Ya 33 67,3 16 61,5 0,615§ 0,058 1,29 (0,48 – 3,47)
Tidak 16 32,7 10 38,5
Konsumsi garam
Sering 45 91,8 25 96,2 0,653¥ 0,082 0,45 (0,05 – 4,25)
Jarang 4 8,2 1 3,8
Konsumsi lemak
Sering 47 95,9 25 96,2 1,000¥ 0,006 0,94 (0,08 – 10,88)
Jarang 2 4,1 1 3,8
Kebiasaan merokok
Ya 9 18,4 8 30,8 0,222§ 0,140 0,51 (0,17 – 1,53)
Tidak 40 81,6 18 69,2
Konsumsi alkohol
Ya 2 4,1 2 7,7 0,606¥ 0,076 0,51 (0,07 – 3,85)
Tidak 47 95,9 24 92,3
Olah raga teratur
Tidak 27 55,1 13 50 0,673§ 0,049 1,23 (0,47 – 3,18)
Ya 22 44,9 13 50
Ket: * Signifikan; ¥ Fisher’s Exact Test;
§ Pearson Chi Square
114
Tabel Hasil Uji Regresi Logistik
Step Variabel B p Ext(B) IK 95%
1 BMI 0,723 0,175 2,061 0,73 – 5,85
Merokok -0,261 0,672 0,770 0,23 – 2,57
Konstanta -2,728 0,137 0,065
2 BMI 0,755 0,152 2,127 0,76 – 5,98
Konstanta -3,328 0,005 0,036
3 Konstanta -2,105 0,005 0,122
115
Lampiran 4. Surat Pernyataan Persetujuan (Inform Consent)
Surat Pernyataan Persetujuan sebagai Sampel Penelitian
(Informed Consent)
Saya yang bertanda tangan di bawah ini,
Menyatakan dengan kesungguhannya bahwa saya bersedia untuk menjadi sampel
penelitian mahasiswa S-1 Pendidikan Dokter dengan judul “Faktor Risiko Kejadian
Hipertensi pada Pasien yang Berobat di Poliklinik RSUD RAA Soewondo Pati”, dengan
menjawab setiap pertanyaan yang ada pada kuesioner dengan jujur dan apa adanya.
Informasi yang saudara berikan akan dijaga kerahasiaannya. Penelitian ini hanya
akan dipergunakan untuk kepentingan pendidikan serta pengembangan ilmu pengetahuan.
Demikian surat persetujuan ini saya terima setelah mendapat penjelasan
mengenai maksud dan tujuan penelitian tanpa paksaan atau tekanan.
Pati, 2016
Peneliti, Subjek Penelitian,
( Reza Rachman ) ( )
116
Lampiran 5. Kuesioner Penelitian
KUESIONER PENELITIAN
“Faktor Risiko Kejadian Hipertensi pada Pasien di Poliklinik RSUD RAA
Soewondo Kabupaten Pati”
Keterangan Responden (di isi oleh pasien)
1. Nomor :
2. Tanggal pemeriksaan :
3. Hasil pengukuran tekanan darah :
4. Hasil pengukuran tinggi badan :
5. Hasil pengukuran berat badan :
6. BMI = :
Identitas Responden
1. Nama :
2. Alamat :
3. Umur :
4. Jenis kelamin :
5. Pendidikan :
6. Pekerjaan :
117
No. Pertanyaan Jawaban
1. Sejak kapan anda didiagnosis
menderita hipertensi atau darah
tinggi?
2. Apakah anda memiliki riwayat
keluarga menderita hipertensi?
1. Ya
2. Tidak
3. Seberapa banyak anda
mengkonsumsi garam dapur
perhari sebelum menderita
hipertensi?
1. Sering, jika konsumsi garam
≥1 sendok teh per hari.
2. Jarang, jika konsumsi garam
<1 sendok teh per hari.
4. Seberapa banyak anda
mengkonsumsi garam dapur
perhari setelah menderita
hipertensi?
1. Sering, jika konsumsi garam
≥1 sendok teh per hari.
2. Jarang, jika konsumsi garam
<1 sendok teh per hari.
5. Seberapa banyak anda
mengkonsumsi makanan berlemak
sebelum menderita hipertensi?
1. Sering, jika mengkonsumsi
makanan berlemak >3 kali
dalam seminggu.
2. Jarang, jika ≤3 kali seminggu
mengkonsumsi makanan
berlemak dan / atau gorengan
6. Seberapa banyak anda
mengkonsumsi makanan berlemak
sesudah menderita hipertensi?
1. Sering, jika mengkonsumsi
makanan berlemak >3 kali
dalam seminggu.
2. Jarang, jika ≤3 kali seminggu
mengkonsumsi makanan
berlemak dan / atau gorengan
7. Apakah anda memiliki kebiasaan
merokok ?
1. Ya
2. Tidak
8. Apakah anda memiliki kebiasaan
mengkonsumsi alkohol ?
1. Ya
118
2. Tidak
9. Seberapa banyak anda
mengkonsumsi alkohol sebelum
menderita hipertensi?
1. Iya, saya memiliki kebiasaan
mengkonsumsi alkohol ≥ 2
gelas perhari.
2. Iya, saya memiliki kebiasaan
mengkonsumsi alkohol < 2
gelas perhari.
10. Seberapa banyak anda
mengkonsumsi alkohol setelah
menderita hipertensi?
1. Iya, saya memiliki kebiasaan
mengkonsumsi alkohol ≥ 2
gelas perhari.
2. Iya, saya memiliki kebiasaan
mengkonsumsi alkohol < 2
gelas perhari.
11. Apakah anda melakukan olahraga
secara teratur sebelum menderita
hipertensi?
1. Saya melakukan olahraga
tertentu seminggu 3 kali
dengan waktu sekitar 30
menit.
2. Saya tidak pernah melakukan
kegiatan olahraga secara
teratur.
12. Apakah anda melakukan olahraga
secara teratur sebelum menderita
hipertensi?
1. Saya melakukan olahraga
tertentu seminggu 3 kali
dengan waktu sekitar 30
menit.
2. Saya tidak pernah melakukan
kegiatan olahraga secara
teratur.
13. Apakah anda saat ini
mengkonsumsi obat anti hipertensi
?
1. Ya, saat ini saya sedang
mengkonsumsi obat anti
hipertensi.
119
2. Tidak, saat ini saya tidak
sedang mengkonsumsi obat
anti hipertensi.
14. Berapa macam jumlah obat anti
hipertensi yang anda konsumsi saat
ini ?
1. Saat ini mengkonsumsi 1 jenis
obat anti hipertensi.
2. Saat ini mengkonsumsi >1
jenis obat hipertensi.
15. Apakah anda tahu bahwa hipertensi
adalah faktor risiko penyakit
jantung koroner ?
1. Tidak tahu
2. Tahu
16. Apakah anda pernah memeriksakan
faktor risiko penyakit jantung
koroner yang lain, seperti DM dan
kolestrol tinggi ?
1. Pernah
2. Belum pernah
17. Bagaimana hasil pemeriksaan
faktor risiko tersebut ?
1. Ada kelainan, dengan
2. Tidak ada kelainan
120
Lampiran 6. Surat Perijinan Penelitian
121
Lampiran 7. Surat Telah Melakukan Penelitian
122
Lampiran 8. Ethical Clearence
123
124
Lampiran 9. Biodata Mahasiswa
Identitas
Nama : Reza Rachman
NIM : 22010112110033
Tempat / tanggal lahir : Pati, 6 Desember 1993
Jenis kelamin : Laki - laki
Alamat : Jalan Mediatama E 11 Perumahan Taman Setiabudi
Banyumanik, Semarang
Nomor HP : 0811270281
E-mail : [email protected]
Riwayat Pendidikan Formal
1. SD : 2000 Lulus tahun : 2006
2. SMP : 2006 Lulus tahun : 2009
3. SMA : 2009 Lulus tahun : 2012
4. FK UNDIP Masuk tahun 2012
Keanggotaan Organisasi
1. Staf SENIOR HIMA KU 2012/2013
Pengalaman penelitian
1. Judul : Faktor Risiko Kejadian Hipertensi pada Pasien yang Berobat di Poliklinik
RSUD RAA Soewondo Pati.